HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mercedes Robledo Selected Research

Myc associated factor X

11/2014Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
5/2012MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma.
6/2011Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mercedes Robledo Research Topics

Disease

72Neoplasms (Cancer)
05/2022 - 08/2004
32Paraganglioma (Paragangliomas)
01/2022 - 08/2002
22Pheochromocytoma
01/2022 - 08/2013
15Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 04/2005
7Neoplasm Metastasis (Metastasis)
01/2022 - 10/2014
6Hypoxia (Hypoxemia)
10/2020 - 12/2010
5Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 11/2011
5Peripheral Nervous System Diseases (PNS Diseases)
01/2019 - 08/2012
3Melanoma (Melanoma, Malignant)
05/2019 - 01/2016
3Multiple Endocrine Neoplasia Type 2a (MEN 2)
12/2017 - 01/2006
2Disease Progression
11/2020 - 01/2020
2Carcinogenesis
05/2019 - 06/2015
2Ovarian Neoplasms (Ovarian Cancer)
01/2019 - 02/2011
2Adenoma (Adenomas)
01/2017 - 06/2007
2Hyperplasia
01/2017 - 04/2005
2Pituitary Neoplasms (Pituitary Adenoma)
06/2016 - 03/2007
2Genetic Predisposition to Disease (Genetic Predisposition)
11/2015 - 01/2015
2Carcinoma (Carcinomatosis)
02/2011 - 06/2007
2T-Cell Lymphoma (Lymphoma, T Cell)
11/2007 - 08/2004
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2007 - 08/2004
2Lymphoma (Lymphomas)
11/2007 - 08/2004
1Dwarfism
11/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2020
1Hearing Loss (Hearing Impairment)
07/2020
1Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1Inflammation (Inflammations)
05/2019
1Nervous System Diseases (Neurological Disorders)
05/2019
1Kidney Neoplasms (Kidney Cancer)
05/2019
1Leiomyoma (Uterine Fibroids)
05/2019
1Seroma
01/2019
1Angiomyolipoma
05/2018
1Starvation
01/2018

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
11/2020 - 08/2002
15Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2022 - 04/2005
12DNA (Deoxyribonucleic Acid)IBA
11/2020 - 08/2004
11Messenger RNA (mRNA)IBA
01/2020 - 11/2007
10CatecholaminesIBA
01/2022 - 11/2014
9Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2008
8MicroRNAs (MicroRNA)IBA
01/2022 - 02/2011
7Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 02/2011
6EnzymesIBA
05/2022 - 11/2007
5Pharmaceutical PreparationsIBA
01/2017 - 04/2010
43-methoxytyramine (methoxytyramine)IBA
01/2022 - 04/2017
4NormetanephrineIBA
01/2022 - 05/2012
4Phosphotransferases (Kinase)IBA
06/2021 - 08/2013
4MetanephrineIBA
10/2020 - 05/2012
4Tyrosine Kinase InhibitorsIBA
01/2016 - 11/2011
4TubulinIBA
09/2012 - 04/2010
3Adrenergic Agents (Adrenergic Drugs)IBA
01/2022 - 04/2017
3MTOR InhibitorsIBA
01/2020 - 11/2017
3Succinic Acid (Succinate)IBA
01/2019 - 10/2014
3FumaratesIBA
01/2019 - 10/2014
3Myc associated factor XIBA
11/2014 - 06/2011
2Epinephrine (Adrenaline)FDA LinkGeneric
10/2020 - 02/2015
2endothelial PAS domain-containing protein 1IBA
01/2020 - 05/2019
2Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2020 - 04/2019
2Dopamine (Intropin)FDA LinkGeneric
04/2019 - 06/2016
2alpha-hydroxyglutarateIBA
01/2019 - 01/2019
2Fumarate Hydratase (Fumarase)IBA
01/2019 - 05/2014
2Complementary DNA (cDNA)IBA
01/2018 - 07/2012
2Sunitinib (Sutent)FDA Link
01/2018 - 11/2011
2Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2018 - 07/2012
2EverolimusFDA Link
01/2018 - 01/2017
2temsirolimusFDA Link
01/2018 - 11/2017
2Mechanistic Target of Rapamycin Complex 1IBA
11/2017 - 01/2017
2RacivirIBA
01/2017 - 06/2007
2ParaffinIBA
01/2017 - 07/2012
2SuspensionsIBA
01/2017 - 01/2015
2Tumor Biomarkers (Tumor Markers)IBA
03/2016 - 08/2004
2Cyclin-Dependent Kinase Inhibitor p27IBA
03/2012 - 06/2007
2Cytochrome P-450 CYP3AIBA
11/2011 - 11/2007
1Thyrotropin AlfaFDA LinkGeneric
01/2022
1Circulating MicroRNAIBA
01/2022
1Telomerase (Telomerase Reverse Transcriptase)IBA
09/2021
1Sialic AcidsIBA
06/2021
1P-2 (P 2)IBA
06/2021
1Inositol (Myoinositol)IBA
06/2021
1KynurenineIBA
06/2021
1xanthurenic acidIBA
06/2021
1tryptophyltryptophanIBA
11/2020
1ChromatinIBA
11/2020
112S ribosomal RNAIBA
07/2020
1AminoglycosidesIBA
07/2020
1PolyaminesIBA
01/2020
1TOR Serine-Threonine KinasesIBA
01/2020
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2019
1Tricarboxylic AcidsIBA
05/2019
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
04/2019
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2019
1Immune Checkpoint InhibitorsIBA
01/2019
1Hormones (Hormone)IBA
01/2019
1Malate Dehydrogenase (Dehydrogenase, Malate)IBA
12/2018
1MethyltransferasesIBA
12/2018
1A-Form DNA (A-DNA)IBA
12/2018
1Sirolimus (Rapamycin)FDA Link
05/2018

Therapy/Procedure

6Therapeutics
05/2022 - 11/2007
3Drug Therapy (Chemotherapy)
01/2019 - 11/2006
3Drug Tapering
01/2017 - 11/2011
1Lymph Node Excision (Lymph Node Dissection)
01/2019
1Nephrectomy
05/2018